Xiaoli Lan

7.0k total citations · 1 hit paper
263 papers, 5.0k citations indexed

About

Xiaoli Lan is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Xiaoli Lan has authored 263 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Radiology, Nuclear Medicine and Imaging, 91 papers in Oncology and 57 papers in Molecular Biology. Recurrent topics in Xiaoli Lan's work include Radiopharmaceutical Chemistry and Applications (46 papers), Peptidase Inhibition and Analysis (42 papers) and Nanoplatforms for cancer theranostics (36 papers). Xiaoli Lan is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (46 papers), Peptidase Inhibition and Analysis (42 papers) and Nanoplatforms for cancer theranostics (36 papers). Xiaoli Lan collaborates with scholars based in China, United States and Iran. Xiaoli Lan's co-authors include Chunxia Qin, Weibo Cai, Yongxue Zhang, Yongkang Gai, Dawei Jiang, Qingyao Liu, Mengting Li, Dalong Ni, Fan Hu and Fuqiang Shao and has published in prestigious journals such as Chemical Society Reviews, Advanced Materials and Angewandte Chemie International Edition.

In The Last Decade

Xiaoli Lan

247 papers receiving 4.9k citations

Hit Papers

Effective Wound Healing Enabled by Discrete Alternative E... 2018 2026 2020 2023 2018 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoli Lan China 38 1.6k 1.3k 1.3k 1.2k 726 263 5.0k
Shaoli Song China 35 2.0k 1.2× 1.2k 0.9× 1.3k 1.0× 874 0.7× 1.0k 1.4× 218 5.1k
Daniel L.J. Thorek United States 35 1.3k 0.8× 1.2k 0.9× 1.2k 1.0× 692 0.6× 646 0.9× 106 4.4k
Olivier Gheysens Belgium 36 1.2k 0.8× 1.4k 1.0× 926 0.7× 675 0.6× 599 0.8× 191 5.1k
Jian He China 42 2.0k 1.2× 1.6k 1.2× 1.2k 1.0× 607 0.5× 1.7k 2.3× 242 6.2k
Fan Wang China 43 1.6k 1.0× 1.6k 1.2× 2.2k 1.7× 1.7k 1.4× 713 1.0× 222 6.1k
Wayne L. Monsky United States 27 1.6k 1.0× 1.7k 1.2× 739 0.6× 895 0.8× 350 0.5× 84 5.2k
Abhijit De India 37 1.4k 0.9× 3.0k 2.2× 504 0.4× 910 0.8× 456 0.6× 119 5.6k
Yongping Su China 34 1.7k 1.1× 1.9k 1.4× 515 0.4× 420 0.4× 909 1.3× 141 5.4k
Christoph E. Hagemeyer Australia 41 1.4k 0.9× 1.4k 1.0× 580 0.5× 398 0.3× 810 1.1× 128 5.4k
Byeong‐Cheol Ahn South Korea 42 1.0k 0.6× 2.8k 2.1× 1.1k 0.9× 912 0.8× 393 0.5× 274 6.6k

Countries citing papers authored by Xiaoli Lan

Since Specialization
Citations

This map shows the geographic impact of Xiaoli Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Lan more than expected).

Fields of papers citing papers by Xiaoli Lan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoli Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Lan. The network helps show where Xiaoli Lan may publish in the future.

Co-authorship network of co-authors of Xiaoli Lan

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoli Lan. A scholar is included among the top collaborators of Xiaoli Lan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoli Lan. Xiaoli Lan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Song, Yangmeihui, Jimin Hong, Axel Rominger, et al.. (2025). FAPI PET Versus FDG PET/CT in Gastrointestinal Cancers: An Overview. Seminars in Nuclear Medicine. 55(5). 710–723. 2 indexed citations
3.
Li, Xiang, Xiaohui Lv, Tingting Han, et al.. (2024). Surgical evidence-based comparison of [68Ga]Ga-FAPI-04 PET and MRI-DWI for assisting debulking surgery in ovarian cancer patients. European Journal of Nuclear Medicine and Molecular Imaging. 51(6). 1773–1785. 5 indexed citations
4.
Wang, Yan, et al.. (2024). Peptide-based PET tracer targeting LAG-3 for evaluating the efficacy of immunotherapy in melanoma. Journal for ImmunoTherapy of Cancer. 12(7). e009010–e009010. 3 indexed citations
5.
Song, Yangmeihui, Chunxia Qin, Yixiong Chen, et al.. (2024). Non-invasive visualization of liver fibrosis with [68Ga]Ga-DOTA-FAPI-04 PET from preclinical insights to clinical translation. European Journal of Nuclear Medicine and Molecular Imaging. 51(12). 3572–3584. 7 indexed citations
6.
Yang, Wei‐Dong, Fei Kang, Yue Chen, et al.. (2024). Landscape of Nuclear Medicine in China and Its Progress on Theranostics. Journal of Nuclear Medicine. 65(Supplement 1). 29S–37S. 11 indexed citations
8.
Liu, Yu, Li Zhang, Huanyu Chen, et al.. (2023). Quantitative assessment of renal functions using 68Ga-EDTA dynamic PET imaging in renal injury in mice of different origins. Frontiers in Medicine. 10. 1143473–1143473. 1 indexed citations
9.
Zhu, Ziyang, et al.. (2023). NIRF/PET imaging of γδ T cells via metabolic glycoengineering and bioorthogonal labeling. Chemical Engineering Journal. 470. 144127–144127. 3 indexed citations
10.
Ruan, Weiwei, et al.. (2023). Added value of regional 18F-FDG PET/MRI-assisted whole-body 18F-FDG PET/CT in malignant ascites with unknown primary origin. SHILAP Revista de lepidopterología. 7(1). 22–22. 1 indexed citations
11.
Yu, Long, Fuqiang Shao, Hao Ji, et al.. (2022). Visualizing γδ T cells by very late antigen-4-targeted positron emission tomography. European Journal of Nuclear Medicine and Molecular Imaging. 49(12). 4156–4170. 2 indexed citations
12.
Yu, Long, Hao Ji, Qingyao Liu, et al.. (2022). Development and Evaluation of a Peptide Heterodimeric Tracer Targeting CXCR4 and Integrin αvβ3 for Pancreatic Cancer Imaging. Pharmaceutics. 14(9). 1791–1791. 14 indexed citations
13.
Wang, Yichun, Mengting Li, Xiao Zhang, et al.. (2022). 18F-5-FPN: A Specific Probe for Monitoring Photothermal Therapy Response in Malignant Melanoma. Molecular Pharmaceutics. 20(1). 572–581. 1 indexed citations
14.
Fang, Hanyi, Yongkang Gai, Sheng Wang, et al.. (2021). Biomimetic oxygen delivery nanoparticles for enhancing photodynamic therapy in triple-negative breast cancer. Journal of Nanobiotechnology. 19(1). 63 indexed citations
15.
Liu, Qingyao, Yongkang Gai, Yaqi Chen, Xiaoli Lan, & Dawei Jiang. (2021). Escherichiacoli Nissle 1917 as a Novel Microrobot for Tumor-Targeted Imaging and Therapy. Pharmaceutics. 13(8). 1226–1226. 38 indexed citations
17.
Zhang, Xiao, et al.. (2018). Evaluation of99mTc-HYNIC-VCAM-1scFvas a Potential Qualitative and Semiquantitative Probe Targeting Various Tumors. Contrast Media & Molecular Imaging. 2018. 1–8. 3 indexed citations
18.
Zhang, Yingying, Yongxue Zhang, Xiaotian Xia, et al.. (2017). Synthesis and Bioevaluation of Iodine-131 Directly Labeled Cyclic RGD-PEGylated Gold Nanorods for Tumor-Targeted Imaging. Contrast Media & Molecular Imaging. 2017. 1–10. 31 indexed citations
19.
Zhang, Xiao, Yichun Wang, Fengzhen Zhang, et al.. (2016). SPECT and fluorescence imaging of vulnerable atherosclerotic plaque with a vascular cell adhesion molecule 1 single-chain antibody fragment. Atherosclerosis. 254. 263–270. 21 indexed citations
20.
Lan, Xiaoli, et al.. (2013). Efficacy of ~(18)F-FDG PET/CT in diagnosis and prognosis for nasopharyngeal carcinoma patients during follow-up after comprehensive therapy. Zhongguo yixue yingxiang jishu. 29(3). 349–353. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026